Ratio of Aβ42/P-tau 181p in CSF is associated with aberrant default mode network in AD

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Li, Xiaozhen ^a   Li, Tie Qiang ^a   Andreasen, Niels ^a   Wiberg, Maria Kristoffersen ^a   Westman, Eric ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CEREBROSPINAL FLUID; COGNITIVE DEFECT; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHORYLATION; TAU PROTEINS;

EID: 84874590994     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01339     Document Type: Article

References (42)

1. Blennow, K., De Leon, M. J. & Zetterberg, H. Alzheimer's disease. Lancet 368, 387-403 (2006) (Pubitemid 44108123)
2. Morris, J. C. & Price, J. L. Pathologic Correlates of Nondemented Aging, Mild Cognitive Impairment, and Early-Stage Alzheimer's Disease. J Mol Neurosci 17, 101-118 (2001) (Pubitemid 33063515)
3. Arendt, T. Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118, 167-79 (2009)
4. Tapiola, T. et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-9 (2009)
5. Engelborghs, S. & Bastard, N. Le The Impact of Cerebrospinal Fluid Biomarkers on the Diagnosis of Alzheimer's Disease. Mol Diagn Ther 16, 135-141 (2012)
6. Vandermeeren, M. et al. Detection of Proteins inNormal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme-Linked Immunosorbent Assay. J Neurochem 61, 1828-1834 (1993) (Pubitemid 23317209)
7. Vanmechelen, E. et al. Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285, 49-52 (2000) (Pubitemid 30224621)
8. Andreasen, N. et al. Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58, 373-9 (2001) (Pubitemid 32217453)
9. Schoonenboom, N. S. M. et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78, 47-54 (2012)
10. Ibach, B. et al. Cerebrospinal fluid tau and beta-amyloid in Alzheimer patients, disease controls and an age-matched random sample. Neurobiol Aging 27, 1202-11 (2006) (Pubitemid 44067302)
11. Sunderland, T. et al. Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease. JAMA 289, 2094-2103 (2003)
12. Petersen, R. C. et al. Aging, Memory, and Mild Cognitive Impairment. Int Psychogeriatr 9, 65-69 (1997) (Pubitemid 28045341)
13. Petersen, R. C. et al. Current concepts in mild cognitive impairment. Arch Neurol 58, 1985-92 (2001) (Pubitemid 33143977)
14. Reisberg, B. & Gauthier, S. Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. Int Psychogeriatr 20, 1-16 (2008) (Pubitemid 350256071)
15. Hansson, O. et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5, 228-34 (2006) (Pubitemid 43238346)
16. Mattsson, N. et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393 (2009)
17. Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 7, 280-292 (2011)
18. Raichle, M. E. et al. A default mode of brain function. Proc Natl Acad Sci U S A 98, 676-82 (2001) (Pubitemid 32105102)
19. Buckner, R. L., Andrews-Hanna, J. R. & Schacter, D. L. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124, 1-38 (2008) (Pubitemid 351506788)
20. Greicius, M. D., Srivastava, G., Reiss, A. L. & Menon, V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc Natl Acad Sci U S A 101, 4637-4642 (2004) (Pubitemid 38437463)
21. Li, T.-Q. & Wahlund, L.-O. The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques. Acta Radiol 52, 211-22 (2011)
22. Petrella, J. R., Sheldon, F. C., Prince, S. E., Calhoun, V. D. & Doraiswamy, P. M. Default mode network connectivity in stable vs progressive mild cognitive impairment. Neurology 76, 511-7 (2011)
23. Buckner, R. L. et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25, 7709-17 (2005) (Pubitemid 41208641)
24. Kennedy, K. M. et al. Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan. Neuroimage 62, 1-8 (2012)
25. Sheline, Y. I. et al. Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 67, 584-7 (2010)
26. Petrie, E. C. et al. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Arch Neurol 66, 632-637 (2009)
27. Maddalena, A. et al. Biochemical Diagnosis of Alzheimer Disease by Measuring the Cerebrospinal Fluid Ratio of Phosphorylated tau Protein to b-Amyloid Peptide 42. Arch Neurol 60, 1202-1206 (2003) (Pubitemid 37099624)
28. Seppälä, T. T. et al. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology 78, 1568-75 (2012)
29. Blennow, K. & Hampel, H. Review CSF markers for incipient Alzheimer's disease CSF markers for incipient AD. Lancet Neurol 2, 605-613 (2003) (Pubitemid 37162569)
30. Visser, P. J. et al. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol 8, 619-27 (2009)
31. Herukka, S.-K., Hallikainen, M., Soininen, H. &Pirttilä, T. CSFAbeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. Neurology 64, 1294-7 (2005)
32. Wang, K. et al. Altered functional connectivity in early Alzheimer's disease: a resting-state fMRI study. Hum Brain Mapp 28, 967-78 (2007) (Pubitemid 47549702)
33. Bai, F. et al. Default-mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: a combined structural and resting-state functional MRI study. Neurosci Lett 438, 111-5 (2008)
34. Jones, D. T. et al. Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology 77, 1524-31 (2011)
35. Zhang, H. Y. et al. Resting Brain Connectivity: Changes during the Progress of Alzheimer Disease. Radiology 256, 598-606 (2010)
36. Luo, L. et al. Constrained source-based morphometry identifies structural networks associated with default mode network. Brain Connect 2, 33-43 (2012)
37. Mak, H. K. F. et al. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-Tesla. J Alzheimers Dis 31, 33-44 (2012)
38. Codispoti, K.-E. T. et al. Longitudinal brain activity changes in asymptomatic Alzheimer disease. Brain Behav 2, 221-30 (2012)
39. Tosun, D., Schuff, N., Mathis, C. a, Jagust, W. &Weiner, M. W. Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain 134, 1077-88 (2011)
40. Winblad, B. et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-6 (2004) (Pubitemid 39222993)
41. Andreasen, N. et al. Cerebrospinal fluid b-amyloid (1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56, 673-680 (1999) (Pubitemid 29266465)
42. Koch, W. et al. Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter? Neuroimage 51, 280-7 (2010).